4.2 Review

Recent Advances in the Discovery and Preclinical Testing of Novel Compounds for the Prevention and/or Treatment of Alcohol Use Disorders

Journal

Publisher

WILEY
DOI: 10.1111/j.1530-0277.2012.01846.x

Keywords

GABAA Receptors; Purinergic Receptors; Glial Cell Line-Derived Neurotrophic Factor; Dihydromyricetin; Ganaxolone; Ivermectin

Funding

  1. NIAAA [AA007680, AA017991, AA013922]
  2. Integrative Neurosciences Initiative on Alcoholism [AA013517, AA012439, AA016981]
  3. Department of Veterans Affairs [RO1 AA014366]
  4. State of California for Medical Research on Alcohol and Substance Abuse through the University of California San Francisco
  5. OHSU
  6. [T32 AA07468]

Ask authors/readers for more resources

Alcohol abuse and dependence have a staggering socioeconomic impact, yet current therapeutic strategies are largely inadequate to treat these disorders. Thus, the development of new strategies that can effectively prevent alcohol use disorders (AUDs) is of paramount importance. Currently approved medications attempt to deter alcohol intake by blocking ethanol metabolism or by targeting the neurochemical systems downstream of the cascades leading to craving and dependence. Unfortunately, these medications have provided only limited success as indicated by the continued high rates of alcohol abuse and alcoholism. The lack of currently available effective treatment strategies is highlighted by the urgent call by the NIAAA to find new and paradigm-changing therapeutics to either prevent or treat alcohol-related problems. This mini-review highlights recent findings from 4 laboratories with a focus on compounds that have the potential to be novel therapeutic agents that can be developed for the prevention and/or treatment of AUDs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available